The 20 million doses allocated this month for direct acquisition by state governments are the only ones to be offered for free for those under the age of 45. India has roughly 595 million people between the ages of 18 and 44, according to the government’s Technical Group of Population Projections. Among the prominent vaccine makers that still have capacity are Pfizer-BioNTech (800 million doses), Novavax (300 million doses) and Gamaleya Institute (1.43 billion doses). The Centre’s affidavit also identified expected vaccine production numbers for May: Serum Institute of India, which makes Covishield, was expected to produce 65 million doses, and Bharat Biotech, which makes Covaxin, is expected to churn out 20 million doses. According to the Co-WIN dashboard, 173.7 million doses of coronavirus vaccines have been administered to people in India, of which 136.5 million are first doses.

Source: Hindustan Times May 11, 2021 19:18 UTC